Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Cash from Financing Activities came in at -$41000.0 in Q1 2026, down 156.25% on a QoQ basis from -$16000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Cash from Financing Activities data on file, last reported at -$41000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to -$41000.0 in Q1 2026; TTM through Mar 2026 was -$91000.0, a 93.62% decrease from a year earlier, with the FY2025 full-year figure at -$50000.0, up 65.52% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$41000.0, down from -$16000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for CWBHF reached as high as $52.7 million in Q4 2022 and fell as low as -$265000.0 in Q3 2022.
- Historically, Cash from Financing Activities has averaged $3.2 million across 5 years, with a median of -$22500.0 in 2024.
- On a YoY basis, Cash from Financing Activities climbed as much as 883.65% in 2022 and fell as far as 393.75% in 2022.
- Year by year, Cash from Financing Activities stood at $52.7 million in 2022, then tumbled by 100.09% to -$49000.0 in 2023, then soared by 75.51% to -$12000.0 in 2024, then plunged by 33.33% to -$16000.0 in 2025, then tumbled by 156.25% to -$41000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$41000.0 in Q1 2026, -$16000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -840.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -494.13 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.48 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -203.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -65.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -127,000.00 |
| Sep 30, 2023 | -127,000.00 |